Use of SGLT-2 inhibitor in COVID-19: A cautionary tale

被引:2
|
作者
Yousaf, Zohaib [1 ]
Munir, Waqar [1 ]
Hammamy, Riyadh Ali Mohammed [1 ]
机构
[1] Hazm Mebaireek Gen Hosp, Hamad Med Corp, Dept Med, Doha, Qatar
来源
MEDCOMM | 2021年 / 2卷 / 01期
关键词
DIABETIC-KETOACIDOSIS;
D O I
10.1002/mco2.45
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:114 / 116
页数:3
相关论文
共 50 条
  • [31] Acute interstitial nephritis related to SGLT-2 inhibitor
    Bnaya, Alon
    Itzkowitz, Eyal
    Atrash, Jawad
    Abu-Alfeilat, Mohsen
    Shavit, Linda
    POSTGRADUATE MEDICAL JOURNAL, 2022, 98 (1164) : 740 - 741
  • [32] Rapid Turn From Cirrhosis to Encephalopathy Following COVID-19 Infection: A Cautionary Tale
    Chowdhury, Tutul
    Sultana, Jakia
    Dutta, Jui
    Gousy, Nicole
    Hassan, Khondokar N.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [33] Outbreak of MRSA in a Gynecology/Obstetrics Department during the COVID-19 Pandemic: A Cautionary Tale
    Moellers, Mareike
    Von Wahlde, Marie-Kristin
    Schuler, Franziska
    Mellmann, Alexander
    Boeing, Christian
    Schwierzeck, Vera
    Schneider, Julia Sophie
    Kampmeier, Stefanie
    MICROORGANISMS, 2022, 10 (04)
  • [34] Two clinical cases of adjunctive use of a SGLT-2 inhibitor in type 1 diabetes
    Siegmund, Thorsten
    Javier Ampudia-Blasco, Francisco
    Schnell, Oliver
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 162
  • [35] Timing of Lung Transplantation for Seemingly Irreversible COVID-19 Lung Disease: A Cautionary Tale
    Turner, G.
    Weigt, S.
    Britton, I.
    Derhovanessian, A.
    Gudzenko, V.
    Ramsey, A. L.
    Saggar, R.
    Shino, M. Y.
    Ardehali, A.
    Sayah, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [36] Azithromycin use in Covid-19: A tale of changing guidelines
    Gupta, Harish
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2022, 11 (07) : 3399 - 3400
  • [37] RHABDOMYOLYSIS WITH COVID-19 AND NYQUIL USE: A SYNERGISTIC TALE
    Shrivastava, Mashu
    Jain, Ayushi
    Simkhada, Shila
    Armendariz, Barbara
    Asija, Udit
    Klamp, Douglas
    CHEST, 2023, 164 (04) : 1393A - 1394A
  • [38] Diabetes and COVID-19: A Tale of 2 Pandemics
    Rizvi, Ali A.
    Janez, Andrei
    Al Mahmeed, Wael
    Rizzo, Manfredi
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2021, 78 (01) : 1 - 2
  • [39] Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors
    Grempler, R.
    Thomas, L.
    Eckhardt, M.
    Himmelsbach, F.
    Sauer, A.
    Sharp, D. E.
    Bakker, R. A.
    Mark, M.
    Klein, T.
    Eickelmann, P.
    DIABETES OBESITY & METABOLISM, 2012, 14 (01): : 83 - 90
  • [40] "The COVID-19 Generation": A Cautionary Note
    Rudolph, Cort W.
    Zacher, Hannes
    WORK AGING AND RETIREMENT, 2020, 6 (03) : 139 - 145